Zuellig, multinationals blasted for hurting patients

Local pharmacists and doctors has recently accused Zuellig Pharma Korea (ZPK) and foreign-invested pharmaceutical firms of undermining patient benefits by exploiting their powerful market position, calling their business activity a “virtual monopoly.’’

The Korean Pharmaceutical Association and the Korea Medical Association in Daegu criticized ZPK for discouraging fair competition and hurting...